Elionova AG develops synthetic hydrogel platforms and pre‑developed ex‑vivo tumor stroma models for cancer research. The company supplies the 3DProSeed® platform and screening‑compatible assays and offers development and manufacturing services for hydrogel formulations, surface coatings and related characterization for CROs, CDMOs and biopharma customers.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
3D cell culture plate with pre-assembled synthetic, animal-free hydrogels; ready for cell-based assays, compatible with automation, with a hydrogel surface for cell infiltration into 3D.
3DProSeed StromaLine
Pre-designed ex vivo stroma models for tumour-stroma interactions, screening and disease research; available with fibroblast, CAF, MSC and vascular niche models, as well as research collaborations and licences.
Development and Manufacturing Services of Hydrogels
Development, manufacturing and characterization of hydrogel formulations, coatings and tools; bioconjugated polymers, hydrogel surface coatings and surface structuring, soft polymer particles and advisory services.
Knowledge
No knowledge articles yet
Once Elionova AG has claimed this profile, we'll publish editorial articles and case studies here together.